HLN
Haleon plc
NYSE: HLN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$9.24
-1.49% today
Updated 2026-05-04
Market cap
$41.69B
P/E ratio
18.76
P/S ratio
3.78x
EPS (TTM)
$0.50
Dividend yield
0.77%
52W range
$9 – $11
Volume
8.3M
WallStSmart proprietary scores
63
out of 100
Grade: C+
Hold
Investment rating
5.3
Growth
C+5.5
Quality
C+7.0
Profitability
B+4.0
Valuation
C5/9
Piotroski F-Score
Moderate
2.2
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →198 stocks currently score above 75
Price targets
Analyst target
$11.74
+27.06%
12-Month target
$12.19
+31.93%
Intrinsic (DCF)
$9.10
Margin of safety
-22.64%
2 Strong Buy1 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $1.26B — positive
Risks
- 22.64% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $10.86B | $11.30B | $11.23B | $10.79B | $11.03B | $11.8B |
| Net income | $1.06B | $1.05B | $1.44B | $1.63B | $855.69M | — |
| EPS | — | — | — | — | $0.50 | $0.21 |
| Free cash flow | $1.74B | $1.76B | $2.05B | $1.97B | $1.26B | — |
| Profit margin | 9.76% | 9.28% | 12.84% | 15.11% | 15.10% | — |
Peer comparison
Smart narrative
Haleon plc trades at $9.24. representing a P/E of 18.76x trailing earnings. Our Smart Value Score of 63/100 indicates the stock is good. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 2.19, it sits in the grey zone. TTM revenue stands at $11.03B. with profit margins at 15.10%. Our DCF model estimates intrinsic value at $9.10.
Frequently asked questions
What is Haleon plc's stock price?
Haleon plc (HLN) trades at $9.24.
Is Haleon plc overvalued?
Smart Value Score 63/100 (Grade C+, Hold). DCF value $9.10.
What is the price target of Haleon plc (HLN)?
The analyst target price is $11.74, representing +27.1% upside from the current price of $9.24.
What is the intrinsic value of Haleon plc (HLN)?
Based on our DCF model, intrinsic value is $9.10, a -22.6% margin of safety versus $9.24.
What is the future stock price of HLN by 2030?
Our research-backed model estimates Haleon plc could reach $35.77 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is Haleon plc's revenue?
TTM revenue is $11.03B.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
2.19 — grey zone.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio3.78x
ROE10.30%
Beta0.33
50D MA$10.04
200D MA$9.81
Shares out4.44B
Float8.86B
Short ratio—
Avg volume8.3M
Performance
1 week-0.95%
1 month-5.54%
3 months-10.58%
YTD-7.22%
1 year—
3 years—
5 years—